Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL3156594 | 0.93 | GAA (0.34) | LMNATSHRHSD17B10RAB9AGAA | |
| SCHEMBL17203573 | 0.90 | MEN1 (0.31) | GAAMEN1KMT2AALDH1A1HPGD | |
| SCHEMBL18527602 | 0.80 | GABRA1 (0.37) | LMNATSHRGAASMN1; SMN2ALDH1A1 | |
| SCHEMBL17203575 | 0.77 | IDH1 (0.31) | — | |
| Hydrochloric Acid SCHEMBL1697483 | 0.74 | MAPT (0.34) | RAB9ASMN1; SMN2ALDH1A1CYP1A2MAPT | |
| Hydrochloric Acid SCHEMBL3156602 | 0.73 | GABRA1 (0.40) | LMNATSHRHSD17B10GAASMN1; SMN2 | |
| SCHEMBL1946824 | 0.71 | HRH3 (0.32) | — | |
| SCHEMBL442095 | 0.71 | ALDH1A1 (0.33) | SMN1; SMN2ALDH1A1MAPTHTT | |
| SCHEMBL21048966 | 0.71 | GABRA1 (0.36) | LMNATSHRGAACYP1A2HPGD | |
| Hydrochloric Acid SCHEMBL1609624 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106459112-B | N-heterocyclic carbene complexes of metalloiminoalkylenes and metallooxoalkylenes and use thereof | 斯图加特大学 | 2020-06-12 | — | — | CN | disclosed |
| US-10072036-B2 | N-heterocyclic carbene complexes of metal imido alkylidenes and metal OXO alkylidenes, and the use of same | Universität Stuttgart (DE) | 2018-09-11 | — | — | US | disclosed |
| US-20170050994-A1 | N-Heterocyclic Carbene Complexes Of Metal Imido Alkylidenes And Metal OXO Alkylidenes, And The Use Of Same | Universität Stuttgart (DE) | 2017-02-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170050994-A1 | N-Heterocyclic Carbene Complexes Of Metal Imido Alkylidenes And Metal OXO Alkylidenes, And The Use Of Same | NR2C2, NR2E3, NR0B2 | LMNA 1689/4885TSHR 1011/4885HSD17B10 1182/4885 |
| US-10072036-B2 | N-heterocyclic carbene complexes of metal imido alkylidenes and metal OXO alkylidenes, and the use of same | NR2C2, NR2E3, NR0B2 | LMNA 1689/4885TSHR 1011/4885HSD17B10 1182/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.